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Abstract Screening asymptomatic subjects to streamline
measures for the prevention of cardiovascular events
remains a major challenge. The established primary pre-
vention risk-scoring methods use equations derived from
large prospective cohort studies, but further fine-tuning of
cardiovascular risk assessment remains important as 25 %
of individuals with low estimated risk may experience
cardiac events. Independent studies provided evidence that
extended risk assessment using coronary artery calcium
quantification may improve risk stratification as it can lead
to reclassification of persons at increased risk. Particularly
in intermediate-risk subjects, coronary artery calcium
scoring can help to correctly identify individuals at highest
risk. Data on the extent of calcification of the ascending
and descending thoracic aorta might be useful for addi-
tional cardiovascular risk stratification. Future analyses and
studies will be required to answer the question of whether
the implementation of such data may allow further fine-
tuning of cardiovascular risk prediction in specific sub-
populations—for instance in women or men with an
increased risk of stroke and/or symptomatic peripheral
vascular disease.
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Cardiovascular events are important causes of death and
disability. Primary prevention to lower the incidence of
such events is of paramount importance. Nevertheless,
screening asymptomatic subjects to streamline preventive
measures remains a major challenge [1]. Classical cardio-
vascular risk factors such as age, gender, cholesterol levels,
blood pressure, and smoking are traditionally employed to
assess the individual risk status, to trigger lifestyle modi-
fication, and to guide drug prescription in order to prevent
cardiovascular events. Ideally, a predictor of the overall
risk of cardiovascular events should be based on a robust
multifactorial model [2–5]. The established primary pre-
vention risk-scoring methods use equations derived from
large prospective cohort studies, such as the European
Systematic Coronary Risk Evaluation Project (SCORE)
[2], the German Prospective Cardiovascular Mu¨nster
(PROCAM) study [3], and the US-American Framingham
Heart and Offspring Studies [4, 5]. These estimated risk
values even appear to be related to coronary plaque pro-
gression rates [7]. Risk prediction models may be most
favorable for the continent, subcontinent, or even country,
from which an underlying data set is derived, which is the
reason for the current coexistence of several cardiovascular
risk scores [2–5]. Current guidelines on dislipidemia use
the estimated individual risk from such scoring systems to
guide lipid-lowering therapy with statins in primary car-
diovascular prevention [6]. The abovementioned facts
underline the importance of prospective cohort studies to
gain information about population-based cardiovascular
event risks, which is required to develop evidence-based
clinical guidelines that have major impact on our daily
clinical practice.
Fine-tuning of cardiovascular risk assessment remains
important as 25 % of individuals with low estimated risk
may experience cardiac events [1]. Independent studies
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provided evidence that extended risk assessment using
coronary artery calcium (CAC) quantification may improve
risk stratification as it can lead to reclassification of persons
at increased risk [8–12]. One example of such large,
population-based cohort studies is the Heinz Nixdorf Recall
Study (4814 participants from the Ruhr metropolitan area in
Germany), which investigates the ability of subclinical
CAC quantification with electron-beam computed tomog-
raphy scanning to predict the risk of major cardiovascular
events at five-year follow-up above and beyond traditional
cardiovascular risk factors [1, 11, 13]. This study demon-
strated that a higher cardiovascular risk burden was asso-
ciated with higher CAC scores and that CAC scoring
improved risk stratification, discrimination, and reclassifi-
cation [1, 11]. Particularly in intermediate-risk subjects,
CAC scoring can help to correctly identify individuals at
highest risk, which might contribute to reducing the number
of coronary events in the general population [1, 11]. A
representative US-American population, the Multi-Ethnic
Study of Atherosclerosis (MESNA), also demonstrated an
incremental prognostic value of absolute CAC scores over
several traditional cardiovascular risk factors [14].
In the current issue of the journal, Raimund Erbel and
his coworkers present interesting thoracic aortic calcifica-
tion (TAC) data derived from the Heinz Nixdorf Recall
cohort study [15]. The extent of calcification of the
ascending and descending thoracic aorta, as determined
with electron-beam computed tomography, was signifi-
cantly associated with CAC burden [15]. While TAC lar-
gely shared cardiovascular risk factors with coronary artery
disease, TAC was independently related to CAC [15].
In fact, these data from a general population in Western
Europe [15] are very welcome. Data on TAC in large,
general populations are scarce and were previously merely
available from US-American populations [16–19]. Wong
et al. studied in 2303 asymptomatic participants the ability
of CAC and TAC to predict coronary heart disease and
cardiovascular events and found that CAC, but not TAC,
showed a strong relation with coronary heart disease and
cardiovascular events [16]. However, in another US-
American study, the MESNA study (n = 6814 of four
ethnic groups), TAC was found to be a strong predictor of
CAC independent of cardiovascular risk factors [17, 18].
Santos et al. even demonstrated in a cohort of 8401
asymptomatic, predominantly white US-Americans,
undergoing cardiac risk factor evaluation and scanning
with electron-beam computed tomography, that the pres-
ence of TAC was associated with all-cause mortality, a
relation that was independent of conventional cardiovas-
cular risk factors and the presence of CAC [19]. In a Dutch
high-risk population of 958 heavy smokers, Jacobs et al.
found that CAC was a stronger predictor of cardiovascular
events than TAC [20]. However, in this quite specific
subpopulation of a lung cancer screening trial, TAC was
stronger associated with vascular disease and events such
as stroke as well as the occurrence of aortic aneurysms and
occlusive peripheral arterial disease [20].
The present report from the Heinz Nixdorf Recall Study
provides valuable computed age and gender-specific per-
centile curves for TAC in a Western European general
population [15]. These percentiles may help to interpret
individual thoracic calcification values and might be useful
for additional cardiovascular risk stratification. Future
analyses and studies will be required to answer the question
of whether the implementation of these data may allow
further fine-tuning of cardiovascular risk prediction in
specific subpopulations—for instance in women or men
with an increased risk of stroke and/or symptomatic
peripheral vascular disease.
Conflict of interest Dr. Hartmann reports no conflict of interest. Dr.
von Birgelen reports no conflict of interest relevant to this manuscript.
He reports to be consultant to and to have received lecture fees or
travel expenses from Abbott, Medtronic, and Boston Scientific; and
he has received a speaker’s honorarium from MSD.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Erbel R, Mo¨hlenkamp S, Moebus S, Heinz Nixdorf Recall Study
Investigative Group et al (2010) Coronary risk stratification,
discrimination, and reclassification improvement based on
quantification of subclinical coronary atherosclerosis: the Heinz
Nixdorf Recall study. J Am Coll Cardiol 56(17):1397–1406
2. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme
for calculating the risk of acute coronary events based on the
10-year follow-up of the prospective cardiovascular Mu¨nster
(PROCAM) study. Circulation 105:310–315
3. Conroy RM, Pyo¨ra¨la¨ K, Fitzgerald AP, for the SCORE project
group et al (2003) Estimation of ten-year risk of fatal cardio-
vascular disease in Europe: the SCORE project. Eur Heart J 24:
987–1003
4. Anderson KM, Wilson PW, Odell PM et al (1991) An updated
coronary risk profile: a statement for health professionals.
Circulation 83:356–362
5. Grundy SM, Pasternak R, Greenland P et al (1999) Assessment of
cardiovascular risk by use of multiple-risk-factor assessment
equations: a statement for healthcare professionals from the
American Heart Association and the American College of Car-
diology. Circulation 100:1481–1492
6. Reiner Z, Catapano AL, De Backer G et al (2011) ESC/EAS
Guidelines for the management of dyslipidaemias: the task force
for the management of dyslipidaemias of the European Society of
Cardiology (ESC) and the European Atherosclerosis Society
(EAS). Eur Heart J 32(14):1769–1818
7. von Birgelen C, Hartmann M, Mintz GS et al (2004) Relationship
between cardiovascular risk as predicted by established risk
scores versus plaque progression as measured by serial
218 Int J Cardiovasc Imaging (2013) 29:217–219
123
intravascular ultrasound in left main coronary arteries. Circula-
tion 110(12):1579–1585
8. Polonsky TS, McClelland RL, Jorgensen NW et al (2010) Cor-
onary artery calcium score and risk classification for coronary
heart disease prediction. JAMA 303(16):1610–1616
9. Greenland P, LaBree L, Azen SP et al (2004) Coronary artery
calcium score combined with Framingham score for risk pre-
diction in asymptomatic individuals. JAMA 291(2):210–215
10. Elias-Smale SE, Proenc¸a RV, Koller MT et al (2010) Coronary
calcium score improves classification of coronary heart disease
risk in the elderly: the Rotterdam study. J Am Coll Cardiol
56(17):1407–1414
11. Mo¨hlenkamp S, Lehmann N, Moebus S et al (2011) Quantifica-
tion of coronary atherosclerosis and inflammation to predict
coronary events and all-cause mortality. J Am Coll Cardiol
57(13):1455–1464
12. Detrano R, Guerci AD, Carr JJ et al (2008) Coronary calcium as a
predictor of coronary events in four racial or ethnic groups.
N Engl J Med 358:1336–1345
13. Schmermund A, Mo¨hlenkamp S, Stang A et al (2002) Assess-
ment of clinically silent atherosclerotic disease and established
and novel risk factors for predicting myocardial infarction and
cardiac death in healthy middle-aged subjects: rationale and
design of the Heinz Nixdorf Recall study. Risk factors, evaluation
of coronary calcium and lifestyle. Am Heart J 144:212–218
14. Budoff MJ, Nasir K, McClelland RL et al (2009) Coronary cal-
cium predicts events better with absolute calcium scores than
age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of
Atherosclerosis). J Am Coll Cardiol 53:345–352
15. Ka¨lsch H, Lehmann N, Mo¨hlenkamp S, Hammer C, Mahabadi
AA, Moebus S, Schmermund A, Stang A, Bauer M, Jo¨ckel KH,
Erbel R (2012) Prevalence of thoracic aortic calcification and its
relationship to cardiovascular risk factors and coronary calcifi-
cation in an unselected population-based cohort: The Heinz
Nixdorf Recall Study. Int J Cardiovasc Imaging. doi:
10.1007/s10554-012-0051-3
16. Wong ND, Gransar H, Shaw L et al (2009) Thoracic aortic cal-
cium versus coronary artery calcium for the prediction of coro-
nary heart disease and cardiovascular disease events. JACC
Cardiovasc Imaging 2(3):319–326
17. Takasu J, Budoff MJ, O’Brien KD et al (2009) Relationship
between coronary artery and descending thoracic aortic calcifi-
cation as detected by computed tomography: the Multi-Ethnic
Study of Atherosclerosis. Atherosclerosis 204(2):440–446
18. Budoff MJ, Nasir K, Katz R et al (2011) Thoracic aortic calci-
fication and coronary heart disease events: the multi-ethnic study
of atherosclerosis (MESA). Atherosclerosis 215(1):196–202
19. Santos RD, Rumberger JA, Budoff MJ et al (2010) Thoracic aorta
calcification detected by electron beam tomography predicts all-
cause mortality. Atherosclerosis 209(1):131–135
20. Jacobs PC, Prokop M, van der Graaf Y et al (2010) Comparing
coronary artery calcium and thoracic aorta calcium for prediction
of all-cause mortality and cardiovascular events on low-dose non-
gated computed tomography in a high-risk population of heavy
smokers. Atherosclerosis 209(2):455–462
Int J Cardiovasc Imaging (2013) 29:217–219 219
123
